Asthma and Medicines – Long-Term Side-Effects, Monitoring and Dose Titration
Authors:
- 6 January 2018
- journal article
- review article
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 85 (9) , 748-756
Abstract
Asthma is a major pediatric respiratory morbidity requiring long-term management. A thorough knowledge of long-term medication side-effects in children is, thus, essential for every physician dealing with childhood asthma. Establishing diagnosis and initiating treatment is just a beginning of the journey. Ongoing monitoring is an essential component of comprehensive asthma management programme. Monitoring includes not only assessment of asthma control but also checking for adherence to treatment, technique of inhaler device use, associated co-morbities, if any, and potential environmental exposure. Various tools – both subjective and objective - are available for assessment of asthma control. However, evidence for their optimum use in different settings and patient groups is lacking and monitoring has to be customized depending on available resources and individual patient characteristics. Patient education is an important component of long-term asthma therapy. The ultimate aim is to achieve optimum asthma control i.e., achieve and maintain control of clinical symptoms, decrease future risk to patients (risk of exacerbations, progressive loss of lung function and development of fixed airflow obstruction, adverse effects of medications) and enabling the child to lead a life without restrictions, at lowest possible dose of drugs. This article reviews the side-effects of medications used for long-term management of asthma and discusses current literature on asthma monitoring and dose titration in pediatric population to help the asthma therapist not only prescribe the drugs rationally but also help the family make right choices for treatment.Keywords
Funding Information
- None
This publication has 57 references indexed in Scilit:
- Hypothalamic-Pituitary-Adrenal Axis Suppression in Asthmatic School ChildrenPediatrics, 2012
- Moderate Dose Inhaled Corticosteroid-Induced Symptomatic Adrenal SuppressionClinical Pediatrics, 2012
- Effect of Inhaled Glucocorticoids in Childhood on Adult HeightNew England Journal of Medicine, 2012
- Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled TrialJAMA, 2012
- Decreased response to inhaled steroids in overweight and obese asthmatic childrenJournal of Allergy and Clinical Immunology, 2011
- Risk of cataracts in the Childhood Asthma Management Program CohortJournal of Allergy and Clinical Immunology, 2010
- Safety and tolerability of montelukast in placebo‐controlled pediatric studies and their open‐label extensionsPediatric Pulmonology, 2009
- Effect of Long-term Corticosteroid Use on Bone Mineral Density in Children: A Prospective Longitudinal Assessment in the Childhood Asthma Management Program (CAMP) StudyPediatrics, 2008
- Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)Thorax, 2007
- Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthmaJournal of Allergy and Clinical Immunology, 1995